Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Ohio Man Developed Terminal Bladder Cancer, New Lawsuit Claims

Filed May 15th, 2013 Laurie

An Ohio man is joining thousands more by claiming that taking the Type 2 diabetes drug treatment Actos caused him to develop bladder cancer.

Like those others and an increasing number of Actos users, the Ohio man also claims that Takeda Pharmaceutical, the maker of Actos, failed to warn of this life-threatening risk associated with its drug despite having evidence that shows a link between the disease and drug.

The Ohio man is being represented in his case by the national law firm of Parker Waichman LLP. The firm’s founding partner, Jerrold S. Parker, has been named to the Plaintiffs’ Steering Committee in an Actos multidistrict litigation (MDL) currently pending in U.S. District Court in Louisiana. More than 1,000 cases have been consolidated into that litigation, including this most recent lawsuit against Takeda.

According to a release announcing the lawsuit, the Ohio man claims he took Actos to treat his case of Type 2 diabetes from June 2002 through February 2007. At that time, he had been diagnosed with bladder cancer. He died later that year, in September, due to bladder cancer. The lawsuit claims that Takeda Pharmaceutical was aware that its drug could significantly increase a person’s risk of developing bladder cancer but failed to warn the public, including health regulators, of this dangerous side effect.

We’ve reported on the alleged cover up of details showing that Takeda knowingly hid the dangers of Actos and on recent studies that have confirmed that taking Actos significantly increases the risk of bladder cancer. In June 2011, the U.S. Food and Drug Administration warned that taking Actos for longer than a year significantly increased a person’s risk of developing bladder cancer.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!